Jason B. Shandell, President and General Counsel at Amphastar Pharmaceuticals, Inc. (AMPH), sold 51,981 shares at $19.52 ($1.0M) on 2018-03-20, disclosed to the SEC on 2018-03-20.
Seasonal sale ($1.0M) by President and General Counsel — this insider has traded AMPH in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.91 | 5,495 | $109K | 10.8% |
| 2 | $19.91 | 6,486 | $129K | 12.7% |
| 3 | $19.37 | 11,707 | $227K | 22.3% |
| 4 | $19.37 | 11,707 | $227K | 22.3% |
| 5 | $19.52 | 8,293 | $162K | 15.9% |
| 6 | $19.52 | 8,293 |
| $162K |
| 15.9% |
| Total | $19.54 avg | 51,981 | $1.0M | 100% |
| Filing → |
| AMPH | SELL | 2019-12-20 | $314K | — | Filing → |
| AMPH | SELL | 2019-09-20 | $313K | — | Filing → |
| AMPH | SELL | 2019-07-12 | $269K | — | Filing → |